2021
DOI: 10.1056/nejmoa2020198
|View full text |Cite
|
Sign up to set email alerts
|

Antibiotic Therapy for 6 or 12 Weeks for Prosthetic Joint Infection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

2
73
3
9

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 130 publications
(87 citation statements)
references
References 16 publications
2
73
3
9
Order By: Relevance
“…These data provide an additional rationale for reductions in antibiotic use that can disrupt microbial communities and lead to adverse events following antimicrobial treatment. Trials are increasingly examining the efficacy of shorter durations of antibiotic treatment for a range of diseases ( 20 , 30 32 ). Future studies of the efficacy and duration of antibacterials should consider the impact on the microbiota and resistome as part of the trial design.…”
Section: Discussionmentioning
confidence: 99%
“…These data provide an additional rationale for reductions in antibiotic use that can disrupt microbial communities and lead to adverse events following antimicrobial treatment. Trials are increasingly examining the efficacy of shorter durations of antibiotic treatment for a range of diseases ( 20 , 30 32 ). Future studies of the efficacy and duration of antibacterials should consider the impact on the microbiota and resistome as part of the trial design.…”
Section: Discussionmentioning
confidence: 99%
“…Eine der wenigen prospektiven Studien von Nelson et al zeigte 1993, dass bei Anwendung von lokaler antimikrobieller Therapie eine kürzere systemische Behandlung möglich erscheint [26]. Eine kürzlich veröffentliche prospektive Studie von Bernard et al hingegen betont die Überlegenheit einer 12-wöchigen antimikrobiellen Therapie [27].…”
Section: Diskussionunclassified
“…However, most of them have been performed in a selected group of patients [ 18 ]. In addition, a 6-week treatment showed a worse outcome in a recent randomized trial from France [ 19 ], especially in acute infections treated with DAIR.…”
Section: Introductionmentioning
confidence: 99%